 |
 |
EURODIAB Study: Anti-HSP27 antibody levels are not a marker of vascular complications in type 1 diabetes Diabetes Care, July 2009
The study describes association of anti–heat shock protein 27 antibody levels and diabetes complications |
 |
 |
 |
Aberrant shedding of megalin and cubilin could contribute to albuminuria in diabetes Diabetes Care, July 2009
The study describes association of microalbuminuria in type 1 diabetes with enhanced excretion of the endocytic multiligand receptors megalin and cubilin |
 |
 |
 |
Modest cognitive decrements are already present at the early stage of type 2 diabetes Diabetes Care, July 2009
The study describes cognition in the early stage of type 2 diabetes |
 |
 |
 |
Adiponectin is favorably associated with lipoprotein particle size Diabetes Care, July 2009
The study describes association between adiponectin and lipoprotein particle size |
 |
 |
 |
Ranirestat may have an effect on motor nerve function in mild to moderate diabetic sensorimotor polyneuropathy Diabetes Care, July 2009
The study describes effect of ranirestat for the management of diabetic sensorimotor polyneuropathy |
 |
 |
 |
Ingested human recombinant interferon-á is safe in young patients with recent-onset T1DM Diabetes Care, July 2009
The study describes effect of ingested interferon-á on â-cell function in children with new-onset type 1 diabetes |
 |
 |
 |
Etanercept preserves â-cell function in pediatric patients newly diagnosed with type 1 diabetes Diabetes Care, July 2009
The study describes effect of etanercept treatment in children with new-onset type 1 diabetes |
 |
 |
 |
Taspoglutide combined with metformin significantly improves fasting and postprandial glucose control Diabetes Care, July 2009
The study describes treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone |
 |
 |
 |
Peripheral arterial disease screening could be improved by using oscillometric measurement of the ankle-brachial pressure index Diabetes Care, July 2009
The study describes automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients |
 |
 |
 |
Liraglutide combined with metformin and a thiazolidinedione is a well-tolerated combination therapy for T2DM Diabetes Care, July 2009
The study describes efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes |
 |
 |
 |
Lower HDL cholesterol is an important risk factor for not only IHD but also CVD Diabetes Care, July 2009
The study describes association of low HDL cholesterol with the risk of stroke in elderly diabetic individuals |
 |
 |
 |
Dallas Heart Study: sRAGE is a novel biomarker that is inversely associated with coronary atherosclerosis Diabetes Care, July 2009
The study describes association between circulating soluble receptor for advanced glycation end products and atherosclerosis |
 |
 |
 |
A recent study indicated a decrease in diabetes-related preventable hospitalizations in the U.S. from 1998 to 2006 Diabetes Care, July 2009
The study describes secular trends in diabetes-related preventable hospitalizations in the United States between 1998–2006 |
 |
 |
 |
Inter99 Cohort: Model incorporating six circulating biomarkers provides objective and quantitative estimate of developing T2DM Diabetes Care, July 2009
The study describes development of a type 2 diabetes risk model from a panel of serum biomarkers |
 |
 |
 |
Glucose values are significantly lower on dialysis days than on nondialysis days despite similar energy intake Diabetes Care, July 2009
The study describes assessment of glycemic control in maintenance hemodialysis patients with type 2 diabetes |
 |
 |
 |
PREDIAS: Prevention of diabetes self-management program significantly modified lifestyle factors associated with an elevated diabetes risk Diabetes Care, July 2009
The study describes effect of prevention of diabetes self-management program on weight, metabolic risk factors, and behavioral outcomes |
 |
 |
 |
Low-carbohydrate diet may have effects on weight and A1C similar to those seen with a low-fat diet Diabetes Care, July 2009
The study describes comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes |
 |
 |
 |
Hypoglycemia is common in diabetic patients hospitalized in the general ward Diabetes Care, July 2009
The study describes hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward |
 |
 |
 |
Providing customized decision support to physicians and/or patients does not improve quality or safety of diabetes care Diabetes Care, July 2009
The study describes effect of customized feedback to patients and providers in improving safety or quality of diabetes care |
 |
 |
 |
Regular and glulisine insulin are equally effective during the acute treatment of diabetic ketoacidosis Diabetes Care, July 2009
The study describes comparison of insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis |
 |
 |
 |
Glycemic control is no better with the more expensive CSII therapy compared with glargine-based MDI therapy Diabetes Care, July 2009
The study describes comparison of a multiple daily insulin injection regimen and continuous subcutaneous insulin infusion in type 1 diabetes |
 |
 |
 |
Depressive symptoms do not necessarily lead to worsened glycemic control Diabetes Care, July 2009
The study describes longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes |
 |
 |
 |
Frequent use of electronic secure messaging is associated with better glycemic control and increased outpatient utilization Diabetes Care, July 2009
The study describes diabetes quality of care and outpatient utilization associated with electronic patient-provider messaging |
 |
 |
 |
24-h mean blood glucose value is <119 mg/dl for the Chinese population Diabetes Care, July 2009
The study describes reference values for continuous glucose monitoring in Chinese subjects |
 |
 |
 |
Higher incidence of congenital malformations in infants of women with T1DM appears to be restricted to male infants only Diabetes Care, July 2009
The study describes male predominance of congenital malformations in infants of women with type 1 diabetes |
 |
 |
 |
Reduced adherence to changes in insulin regimen in hypoglycemia unawareness is compatible with habituation to hypoglycemic stress Diabetes Care, July 2009
The study describes hypoglycemia unawareness and its association with reduced adherence to therapeutic decisions in patients with type 1 diabetes |
 |
 |
 |
Second-meal effect is preserved in type 2 diabetes Diabetes Care, July 2009
The study describes the second-meal phenomenon in type 2 diabetes |
 |
 |
 |
IDEATel had modest effects on clinical outcomes but did not reduce Medicare costs Diabetes Care, July 2009
The study describes costs to Medicare of the Informatics for Diabetes Education and Telemedicine (IDEATel) home telemedicine demonstration |
 |
 |
 |
ATLANTIC DIP study showed suboptimal outcomes Diabetes Care, July 2009
The study describes pregnancy outcome for women with pregestational diabetes along the Irish Atlantic Seaboard |
 |
 |
 |
G82S polymorphism in the RAGE gene is associated with diabetic retinopathy J Endocrinol Invest. May 2009
The study describes association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. |
 |
 |
 |
-174GG genotypes are protected from late diabetic complications by different IL-6 dependent mechanisms Pediatr Res. June 2009
The study describes that the -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. |
 |
 |
 |
A high degree of malnutrition is prevalent in patients with diabetic nephropathy J Ren Nutr. July 2009
The study describes malnutrition, anthropometric, and biochemical abnormalities in patients with diabetic nephropathy. |
 |
 |
 |
Primary intravitreal bevacizumab at doses of 1.25 to 2.5 mg provides stability in diffuse diabetic macular edema Ophthalmology. June 2009
The study describes effect of primary intravitreal bevacizumab for diffuse diabetic macular edema |
 |
 |
 |